Maryland lawmakers announce support of SCOTUS’ decision on abortion drug Mifepristone

13 June 2024- Multiple members of Maryland’s government today announced their approval of the Supreme Court of the United States’ decision to continue to allow the drug Mifepristone to be used to medically induce abortions.

This morning, the Supreme Court unanimously rejected the lawsuit, brought by a group of doctors and organizations, challenging the Food and Drug Administration’s regulation of Mifepristone.

Previously, Attorney General Brown had joined more than two dozen attorneys general across the country in two amicus briefs to the Supreme Court, arguing that the FDA’s determination that the medication abortion drug, Mifepristone, is safe and effective is supported by an overwhelming medical consensus developed over more than two decades of use. The coalition also argued that the FDA’s subsequent regulatory actions – including the authorization of the generic version of Mifepristone, permitting qualified clinicians (other than physicians) to authorize its usage, and enabling its distribution by mail – are all backed by solid evidence.

Attorney General Brown said, “The Supreme Court’s rejection of this lawsuit is a major victory for the right to choose here in Maryland and across the country. Mifepristone remains available in our state, and access to the drug remains intact. Restricting access would have created a disproportionate burden for people of color, low-income and LGBTQIA+ members of society, people living in rural areas, and people with disabilities. Rest assured, however, I remain vigilant. While this battle is won, we know that there are challenges looming that could threaten the reproductive freedoms we cherish here in Maryland. I will continue to take this fight wherever it leads.”

Additionally, Maryland Governor Wes Moore released a statement applauding the decision of the Court to continue to allow the drug’s use.

“Mifepristone has served as a safe and effective healthcare option since the FDA approved two-dose medication for abortions more than 20 years ago for more than 5 million people”, said Moore in a statement.

“Today’s unanimous ruling by the U.S. Supreme Court is a win for reproductive rights. Attempts to restrict access to mifepristone were not based on scientific or legal justification, but political motivation to dismantle women’s rights to make decisions for their own healthcare.

L​et me be clear: reproductive freedom is non-negotiable. Though today’s ruling is a necessary step in the right direction, over a dozen states still have near-total abortion plans in place. Maryland will remain vigilant, continuing to stand proudly with other states to protect reproductive rights and ensure that Maryland remains a safe haven for abortion and reproductive healthcare access.”